Paper Details 
Original Abstract of the Article :
The retrospective study aimed at investigating the safety and clinical efficacy of long-term application of tolvaptan in patients >90 years old with hyponatremia. Although tolvaptan has been used to treat hyponatremia, the effect of its long-term use in elderly patients was unknown.Seven patients ov...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393065/

データ提供:米国国立医学図書館(NLM)

Tolvaptan: A Long-Term Treatment for Hyponatremia in Elderly Patients

This study focuses on the safety and effectiveness of tolvaptan for long-term treatment of hyponatremia in patients over 90 years old. Hyponatremia is a condition where the sodium levels in the blood are too low, which can be a serious issue, particularly in elderly individuals. This research is a real camel's journey through the vast desert of medical knowledge! The study used a retrospective approach, looking back at patient records to investigate the effects of tolvaptan. The researchers discovered that the drug is safe and effective for long-term use in these elderly individuals, boosting sodium levels and improving their overall health.

Tolvaptan: A Beacon of Hope for Elderly Patients

The findings of this study suggest that tolvaptan can be a valuable treatment option for hyponatremia in elderly patients. The researchers observed a significant improvement in serum sodium levels within the first three days of treatment, and this positive effect was sustained throughout the year-long study. It is important to note that no serious complications were observed, which highlights the safety of this medication.

Tolvaptan: A Desert Oasis for Hyponatremia

Tolvaptan, a drug that acts like a camel's thirst quencher, helps to regulate the body's water balance and increase sodium levels. The study emphasizes the importance of carefully monitoring sodium levels in elderly patients and seeking prompt treatment if hyponatremia is detected. This research provides valuable insight into the long-term use of tolvaptan and its potential to improve the health and well-being of elderly individuals.

Dr.Camel's Conclusion

This study is a valuable contribution to our understanding of hyponatremia treatment in elderly patients. It offers a ray of hope for those suffering from this condition, suggesting that tolvaptan can be a safe and effective long-term treatment option. The study's findings highlight the importance of ongoing research in geriatric medicine and the need for personalized treatment approaches for elderly individuals.
Date :
  1. Date Completed 2018-02-20
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

29384972

DOI: Digital Object Identifier

PMC6393065

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.